Clinical Trials Directory

Trials / Terminated

TerminatedNCT01558882

Impact of Essure Tubal Sterilization Devices on the Endometrium

Status
Terminated
Phase
Study type
Observational
Enrollment
2 (actual)
Sponsor
Centre Hospitalier Universitaire de Nīmes · Academic / Other
Sex
Female
Age
35 Years
Healthy volunteers
Not accepted

Summary

The mobilization of natural killer cells (uNK) triggers and coordinates all stages of embryo implantation. They are at the origin of the local secretion of cytokines, growth factors, chemokines affecting vascular development and the local immunotrophisme for the conceptus. The main objective of this study is to evaluate the expression of endometrial uNK cells before and after tubal obstruction by Essure devices. Endoluminal and endometrial levels of various cytokines and growth factors will also be studied.

Conditions

Interventions

TypeNameDescription
DEVICEEssureEssure devices are deployed according to manufacturer's instructions for tubal sterilization.

Timeline

Start date
2014-01-21
Primary completion
2014-11-28
Completion
2014-11-28
First posted
2012-03-20
Last updated
2017-06-19

Locations

4 sites across 1 country: France

Source: ClinicalTrials.gov record NCT01558882. Inclusion in this directory is not an endorsement.